<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36827994</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1646-0758</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Acta medica portuguesa</Title><ISOAbbreviation>Acta Med Port</ISOAbbreviation></Journal><ArticleTitle>Predictors of Long-COVID-19 and its Impact on Quality of Life: Longitudinal Analysis at 3, 6 and 9 Months after Discharge from a Portuguese Centre.</ArticleTitle><Pagination><StartPage>647</StartPage><EndPage>660</EndPage><MedlinePgn>647-660</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.20344/amp.19047</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Long-COVID-19 impacts health-related quality of life (HR-QoL) but data is scarce. The aim of this study was to describe and prospectively assess the prevalence and risk factors for long-COVID-19 after hospital discharge, and to evaluate its impact on patient HR-QoL.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Single-centre longitudinal study including all COVID-19 patients discharged between December 2020 and February 2021. Patients were contacted remotely at three, six and nine months. Data were collected as follows: 1) Long-COVID-19 symptoms were self-reported; 2) HRQoL were assessed using the 3-level EuroQoL-5D (EQ-5D-3L) questionnaire. Pregnant women, demented, bedridden, and non-Portuguese-speaking patients were excluded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The three-, six- and nine-month assessments were completed by 152, 117 and 110 patients (median age: 61 years; male sex: 56.6%). Long-COVID-19 (&#x2265; 1 symptom) was reported by 66.5%, 62.4% and 53.6% of patients and HR-QoL assessment showed impairment of at least some domain in 65.8%, 69.2% and 55.4% of patients at three, six and nine months, respectively. Fatigue was the most common long-COVID-19 symptom. Anxiety/depression domain was the most frequently affected in all three time-points, peaking at six months (39%), followed by pain/discomfort and mobility domains. Long-COVID-19 was associated with the impairment of all EQ-5D-3L domains except for self-care domain at each time-point. Neither intensive care unit admission nor disease severity were associated with long-COVID-19 nor with impairment of any EQ-5D-3L domain. After adjusting for sex, age, frailty status, and comorbid conditions, long-COVID-19 remained significantly associated with HR-QoL impairment at three (OR 4.27, 95% CI 1.92 - 9.52, p &lt; 0.001), six (OR 3.46, 95% CI 1.40 - 8.57, p = 0.007) and nine months (OR 4.13, 95% CI 1.62 - 10.55, p = 0.003) after hospital discharge. In a longitudinal analysis, patients reporting long-COVID-19 at three months had an EQ-5D-3L index value decreased by 0.14 per visit (p &lt; 0.001) compared to those without long-COVID-19 and both groups had a non-significant change in mean EQ-5D-3L index over the nine-month period (time-point assessment, Z = 0.91, p = 0.364).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Clinical sequelae associated with long-COVID-19 can persist for at least nine months after hospital discharge in most patients and can impair long-term HR-QoL in more than half of patients regardless of disease severity, and clinicodemographic characteristics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gaspar</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon; Instituto de Semi&#xf3;tica Cl&#xed;nica. Faculdade de Medicina. Universidade de Lisboa. Lisbon; Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes. Faculdade de Medicina. Universidade de Lisboa. Centro Acad&#xe9;mico de Medicina de Lisboa. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parreira</LastName><ForeName>In&#xea;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gon&#xe7;alves</LastName><ForeName>H&#xe9;lder Diogo</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parlato</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maione</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Pneumology Department. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atalaia Barbacena</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carreiro</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Internal Medicine Department 2. Hospital Santa Maria. Centro Hospitalar Universit&#xe1;rio Lisboa Norte. Lisbon; Cl&#xed;nica Universit&#xe1;ria de Medicina 2. Faculdade de Medicina. Universidade de Lisboa. Lisbon. Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Portugal</Country><MedlineTA>Acta Med Port</MedlineTA><NlmUniqueID>7906803</NlmUniqueID><ISSNLinking>0870-399X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Acta Med Port. 2024 Mar 1;37(3):226-228. doi: 10.20344/amp.20573</RefSource><PMID Version="1">38354422</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Portugal</Keyword><Keyword MajorTopicYN="N">Post-Acute COVID-19 Syndrome</Keyword><Keyword MajorTopicYN="N">Quality of Life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>18</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36827994</ArticleId><ArticleId IdType="doi">10.20344/amp.19047</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>